Archive Newsletter

  1. 06.13.24 -- Frankly Fran: The Key To Regulatory Innovation? Global Harmonization 6/13/2024
    06/13/24 Drug Delivery Leader Newsletter
  2. 06.10.24 -- 4 Strategies To Formulate Poorly Soluble APIs 6/10/2024
    06/10/24 Drug Delivery Leader Newsletter
  3. 06.03.24 -- A Critical Analysis Of FDA Human Factors IFU Guidance For Drug Delivery Devices 6/3/2024
    06/03/24 Drug Delivery Leader Newsletter
  4. Best of May: Top 5 Insights In Drug Formulation and Delivery 5/28/2024
  5. 05.28.24 -- Understanding The New MHRA Requirements For Medical Devices In Great Britain 5/28/2024
    05/28/24 Drug Delivery Leader Newsletter
  6. 05.20.24 -- A Cost-Effective Approach To EU MDR Compliance 5/20/2024
    05/20/24 Drug Delivery Leader Newsletter
  7. 05.16.24 -- Leveraging CDMO Expertise To Streamline Drug Delivery Device Manufacturing 5/16/2024

    05/16/24 Drug Delivery Leader Newsletter

  8. 05.13.24 -- Innovating Bioequivalence: A Novel Approach To Developing Complex Generic Dosage Forms 5/13/2024
    05/13/24 Drug Delivery Leader Newsletter
  9. 05.09.24 -- Frankly Fran: Organizational Imperatives For Combination Product Development 5/9/2024
    05/09/24 Drug Delivery Leader Newsletter
  10. 05.06.24 -- Long Live Design Controls: Navigating The Shift From QSR To QMSR 5/6/2024
    05/06/24 Drug Delivery Leader Newsletter